The DESKTOP III Trial with Philipp Harter
In this episode of the IJGC podcast, Editor-in-Ch…
BMJ talk medicine · BMJ Group
January 24, 202241m 3s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial. Prof. Harter is the director of the Department of Gynecology & Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group.
Highlights:
-Role of surgery for relapsed ovarian cancer is under debate
-DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction
-The data, interpretation and clinical consequences are discussed".